Abstract The aim of the study was to determine the incidence of postoperative deep vein thrombosis (DVT) in Indian patients undergoing surgery for thoracic and abdomino-pelvic malignancies.
Introduction
Though the relationship between thrombosis and malignancy has been well documented, pathophysiological mechanisms remains poorly understood. Studies have shown that malignancy increases the risk of venous thromboembolism (VTE) by two to four times [1, 2] . There is growing evidence to suggest the role of prothrombotic pathways and various cytokines responsible for high incidence of VTE in malignancy [3] . VTE events that may occur perioperatively include deep vein thrombosis (DVT) and pulmonary embolism (PE). Postoperative DVT is a well-studied complication of major oncological surgeries. The presence of malignant disease doubles the risk of DVT, with reported incidences of asymptomatic calf vein thrombi at 40 %-80 %, proximal vein thrombi 10 %-20 %, PE 4 %-10 % and fatal PE 1 %-5 % without perioperative prophylaxis [4] . VTE is reported to be the most common cause of death at 30 days follow-up period among cancer patients undergoing surgery [5] . The risk for thromboembolic complications in cancer surgery may have altered over the years. Refinement in surgical techniques, advanced perioperative care, early postoperative recovery and ambulation may have reduced the risk of VTE [5] .
Though DVT is considered a major postoperative complication in western population, studies support that Asians have low prevalence of DVT [6] . There is scarcity of published literature related to incidence of postoperative DVT in cancer patients in India. A few studies have reported conflicting results about the incidence of DVT in Indian patients [7] [8] [9] ; this has resulted in marked variation in DVT prophylaxis policies across the centres in India. We designed a prospective study to determine incidence of postoperative DVT in cancer patients undergoing thoracic and abdomino-pelvic surgery.
Methods
This prospective observational study was done in a tertiary care centre in North India. The study was approved by the institutional ethics committee for human research. Two hundred and fifty consecutive patients, aged 18-75 years, who underwent curative surgery for thoracic and abdominopelvic malignancies during the period March 2014 to March 2015 were included. All the patients gave their informed consent prior to participation into the study. Patients who underwent emergency surgery or were found to have disseminated malignancy on exploration were not included in the study. Also the patients with past history of DVT or on anticoagulant treatment including aspirin were excluded.
Preoperative duplex colour ultrasonography (USG) of bilateral lower limbs was performed in all patients to rule out chronic DVT; examination of common femoral, superficial femoral, popliteal, anterior and posterior tibial veins was performed. Each patient's demographic details, body mass index (BMI), tumour related features (stage, histology, prior chemotherapy and/or radiotherapy, prior surgeries), indwelling central venous catheter, nature and duration of surgery, type of anaesthesia and post-operative recovery risk factors (time to full ambulation) were recorded. Perioperative pharmacological antithrombotic prophylaxis was not prescribed to any of the patient as per the institutional protocol. Early post-operative mobilization and ambulation was performed in all patients in accordance with a routine protocol. All the patients were examined for clinical signs of VTE. They also underwent colour duplex USG of the bilateral lower limbs -on 7th and 28th day postoperatively to look for presence of DVT.
All the colour duplex USG studies were performed or directly supervised by same radiologist. Presence of DVT was defined as the constant intraluminal defect or a noncompressible venous segment; thrombosis was classified as distal if it involves the calf veins and as proximal if it involves the popliteal or more proximal veins. Patients with involvement of both calf and proximal veins were classified as proximal thrombosis. Isolated muscular or superficial thrombosis was not considered as DVT.
Results
Two hundred and fifty patients were included in the study. Mean age of study population was 48.92 (SD, 13.0) years and 54 % were females. Almost 90 % of the patients were residents of North India. Mean BMI was 24.65 (SD, 4.78) kg/ m 2 ; 11 % were obese (>30 kg/m 2 ) and 9 % were undernourished (<18.5 kg/m 2 ). Majority (80 %) of the patients belonged to Eastern Cooperative Oncology Group (ECOG) performance status 1. Pre-existing medical illnesses were recorded in 9.2 % patients while 15.6 % patients had history of smoking. Common cancer sites were lung (14 %), rectum (12.8 %) and colon (11.2 %). Common histopathological diagnoses were adenocarcinoma (53 %), squamous cell 
Discussion
DVT is well known postoperative complication which has significant impact in terms of morbidity and health care cost. Risk of postoperative DVT has been divided into low, moderate, high and very high risk [4, 10] . Factors specific to malignancy influencing the risk of VTE include site and type of malignancy, stage of the disease, and administration of preoperative chemotherapy [5, 11, 12] . Though majority of the patients in our study were from moderate to high risk category, yet none showed any evidence of DVT/PE. Most of the patients belonged to AJCC/TNM stage II and III, and all underwent curative resection. Two randomized controlled trials (RCTs) published from India showed negligible incidence of DVT after major abdominal and colorectal cancer surgery [13, 14] . A RCT conducted to assess the risk of DVT in North Indian patients undergoing major abdominal surgery reported that none of the 65 patients Postoperative death (sepsis and multi organ failure) 1 (0. 4 %) in two treatment arms developed DVT; Nadroparin prophylaxis was prescribed in 34 patients while 31 had no prophylaxis [13] . Another RCT performed at Tata Memorial Hospital was prematurely closed as none of the 99 colorectal cancer patients who underwent curative surgery (both prophylaxis and no prophylaxis group) were found to develop DVT [14] . These studies highlighted that the Indian patients have low risk of development of postoperative DVT [13] [14] [15] . The reasons for the low frequency of postoperative DVT among the Indian patients may be related to racial, genetic or rheological factors. Stein et al. showed that both incidence and mortality for DVT/PE are lower in Asian population and attributed this to low prevalence of factor V leiden mutation and possibility of lower levels of fibrinogen, factor VIIc and factor VIIIc. They also concluded that clinical assessment of prior probability of VTE should probably be adjusted based on ethnic differences [15, 16 ] . There is need of further studies to clarify the possible decreased prevalence of factor V Leiden mutation and G20210 A mutation in the Indians which may explain the relative immunity of the Indian patients for DVT [13] . Other reasons for low incidence of postoperative DVT in our patient cohort may include good preoperative performance status of the patients, resectable stage of the tumours, meticulous surgical techniques, and early post-operative ambulation.
Use of duplex colour USG as a screening modality for DVT may be considered a limitation of the study. Though it is an operator dependent investigation and may miss small calf vein thrombi, it has its own advantages. It is inexpensive, non-invasive, and widely available and bedside investigation; it, in expert hands, gives accurate results. Though venography is a gold standard investigation for DVT, yet its role as a screening modality is limited in view of its invasiveness and procedure associated morbidity.
Conclusion
The present study reiterates the notion of low frequency of post-operative DVT in Indian patients. Further studies involving multiple regional cancer centres with large sample size will further provide accurate epidemiological data regarding the DVT in Indian patients. Analysis of underlying genetic factors may add new dimension to the etiopathogenesis. There is a need to relook the pharmacological prophylactic policy in Indian cancer patients undergoing major surgeries.
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